Genomic Testing Cooperative and its founder and CEO, Dr. Maher Albitar, were recently featured in the Houston Business Journal in a “Face to Face” profile highlighting GTC’s expansion to the Houston area and the company’s broader mission to advance precision oncology through genomic testing. The article discusses Dr. Albitar’s return to the Houston medical ecosystem, where he previously served at The University of Texas MD Anderson Cancer Center, and explains why Houston’s strong cancer research and clinical innovation environment makes it an important location for GTC’s continued growth.
In the feature, Dr. Albitar emphasized the importance of making advanced genomic profiling more accessible to oncology practices, hospitals, and diagnostic partners. GTC’s new presence in The Woodlands supports this vision by bringing high-quality cancer genomic testing closer to one of the nation’s leading oncology communities. We thank the Houston Business Journal for featuring Dr. Albitar and GTC’s work in precision diagnostics.
Read more from the Houston Business Journal here.